AI Biomed PredictionsMNPR – Mid-2026 NDA filing could reignite Monopar’s rare-disease rally ScanScor Admin / June 9, 2026
AI Biomed PredictionsLXEO – Lexeo Nears Pivotal FDA Decision That Could Reprice Shares ScanScor Admin / May 20, 2026
AI Biomed PredictionsBNTC – Benitec’s next rerating likely hinges on FDA path clarity ScanScor Admin / May 20, 2026
AI Biomed PredictionsABEO – ZEVASKYN launch traction could force ABEO’s next sharp rerating ScanScor Admin / May 20, 2026
AI Biomed PredictionsNGNE – Mid-2026 Rett data could reignite Neurogene’s breakout case ScanScor Admin / May 12, 2026
AI Biomed PredictionsLRMR – June BLA filing could reset Larimar’s risk-reward profile ScanScor Admin / May 10, 2026
AI Biomed PredictionsABEO – ZEVASKYN launch proof could ignite Abeona’s next sharp rerating ScanScor Admin / May 10, 2026
AI Biomed PredictionsOSTX – OSTX Faces Its Defining FDA Pathway Test This Month ScanScor Admin / May 2, 2026
